MY WAY OTC
Generic Name and Formulations:
Levonorgestrel 1.5mg; tabs.
GAVIS Pharmaceuticals, LLC
Indications for MY WAY:
Prevention of pregnancy after known or suspected contraceptive failure or unprotected intercourse. Not for use as regular contraceptive.
Rule out pregnancy first. <17yrs: ℞ only. ≥17yrs: Take one single-dose as soon as possible but no later than 72hrs after unprotected intercourse. If vomiting occurs within 2hrs, may consider repeating dose.
Premenarchal: not applicable.
Known or suspected pregnancy.
See full labeling. Ectopic pregnancy. Not effective in terminating an existing pregnancy. Does not protect against STI/HIV. Not for use in postmenopausal women. Nursing mothers.
Drugs (eg, barbiturates, carbamazepine, phenytoin) or herbal products (eg, St. John's wort) that induce certain enzymes (eg, CYP3A4) may decrease effectiveness.
Heavier menstrual bleeding, nausea, abdominal pain, fatigue, headache, dizziness, breast tenderness.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Triiodothyronine in the Treatment of Bipolar Depression
- Antidepressants Increase Seizure Risk in Youth and Severely Depressed
- Intranasal Oxytocin Reduces Negative Effects, Improves Cognitive Function in Schizophrenia
- E-Cigarettes Associated With More Harms Than Benefits at Population Level
- Examining Rates of Long-Term Opioid Use in Youth With Psychiatric Disorders
- Suicide-Screening Toolkit Can Help Identify Youths at High Risk for Suicide
- Researchers Identify Novel Potential Biomarkers for Autism
- Agoraphobia: An Evolving Understanding of Definitions and Treatment
- Parental Pressure to Diet Linked With Long-term Harm in Adolescents
- Does Access to Medical Cannabis Reduce Risk for Opioid Abuse?
- Personal Health Information Found in Recycling
- Nightmares in Military Personnel Frequently Comorbid With Mental Health Disorders
- Potential for SERMs as Adjunctive Therapy for Schizophrenia
- Addressing Racial Disparities in Bipolar Disorder Treatment
- Negative Symptoms Increase Cardiovascular Risk in Schizophrenia